Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$30.1K Sell
13,080
-4,821
-27% -$11.7K ﹤0.01% 3826
2026
Q1
$42.1K Sell
17,901
-3,802
-18% -$9.2K ﹤0.01% 3362
2025
Q4
$51.9K Buy
21,703
+6,647
+44% +$16.4K ﹤0.01% 2822
2025
Q3
$40K Sell
15,056
-5,352
-26% -$15.8K ﹤0.01% 2209
2025
Q2
$60.6K Buy
+20,408
New +$59.3K ﹤0.01% 1983

Other funds holding XBIT

XTX Topco's XBIT Position: Q2 2026 in Review

XTX Topco reduced its XBiotech (XBIT) stake by 27% in Q2 2026, selling an estimated $11.7K and leaving 13,080 shares worth $30.1K. The position accounts for ﹤0.01% of the portfolio, ranked #3826.

XTX Topco first reported a position in XBIT in Q2 2025 and has held it in 5 quarters since. The position peaked at $60.6K in Q2 2025. 36 funds tracked by Wall St. Rank hold XBIT as of Q2 2026.

  • XTX Topco held 13,080 shares of XBiotech worth $30.1K as of Q2 2026.
  • XTX Topco sold 4,821 XBiotech shares in Q2 2026, an estimated $11.7K.
  • XBiotech made up ﹤0.01% of XTX Topco's portfolio in Q2 2026, its #3826 holding.
  • XTX Topco first reported a position in XBiotech in Q2 2025 and has held it in 5 quarters since.
  • XTX Topco's XBiotech position peaked at $60.6K in Q2 2025.
  • 36 funds tracked by Wall St. Rank held XBiotech as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.